Anaplastic Large Cell Lymphoma, ALK-Negative

Anaplastic Large Cell Lymphoma, ALK-Negative — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Baylor College of Medicine
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04480788	CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study	unknown	Phase 1	9	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Jan 6, 2021	clinicaltrials

Data updated 23 days agoSource updated Jan 6, 2021source: clinicaltrials